Bo Amdi Jensen
- Pathology and Forensic Medicine
- Oncology
- Pulmonary and Respiratory Medicine
- Neurology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Peter de Nully BrownFrancesco d’AmoreAnne Ortved GangPaw JensenMichael PedersenBente FrølundA HjortrupKaren Juul Mylam
- Topics
- Lymphoma Diagnosis and Treatment (5 papers)Multiple Myeloma Research and Treatments (3 papers)Viral-associated cancers and disorders (2 papers)
- Journals
- Quality of Life ResearchAmerican Journal of HematologyInternational Archives of Occupational and Environmental Health
- Partner nations
- DenmarkAustraliaSwitzerland
In The Last Decade
Bo Amdi Jensen
12 papers receiving 124 citations
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 62
- Oncology 40
- Pulmonary and Respiratory Medicine 26
- Neurology 20
- Radiology, Nuclear Medicine and Imaging 16
Countries citing papers authored by Bo Amdi Jensen
This map shows the geographic impact of Bo Amdi Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Amdi Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Amdi Jensen more than expected).
Fields of papers citing papers by Bo Amdi Jensen
This network shows the impact of papers produced by Bo Amdi Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Amdi Jensen. The network helps show where Bo Amdi Jensen may publish in the future.
Co-authorship network of co-authors of Bo Amdi Jensen
This figure shows the co-authorship network connecting the top 25 collaborators of Bo Amdi Jensen. A scholar is included among the top collaborators of Bo Amdi Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Amdi Jensen. Bo Amdi Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 28 | |
| 5 | 20 | |
| 6 | 37 | |
| 7 | 8 | |
| 8 | Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse | 1 |
| 9 | [The Good Medical Department. Results from a national survey of quality in 1998]. | 2 |
| 10 | 7 | |
| 11 | 10 | |
| 12 | 10 |
About Bo Amdi Jensen
Bo Amdi Jensen is a scholar working on Chemical Health and Safety, Pathology and Forensic Medicine and Hematology, having authored 12 papers that have together received 127 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Chemical Health and Safety (3 citations), Pathology and Forensic Medicine (62 citations) and Behavioral Neuroscience (7 citations). Bo Amdi Jensen has collaborated with scholars based in Denmark, Australia and Switzerland. Frequent co-authors include Peter de Nully Brown, Francesco d’Amore, Anne Ortved Gang, Paw Jensen, Michael Pedersen, Bente Frølund, A Hjortrup, Karen Juul Mylam, Christen Lykkegaard Andersen and Niels Abildgaard. Their work appears in journals such as Quality of Life Research, American Journal of Hematology and International Archives of Occupational and Environmental Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.